Lawrence Chen, DPM
Podiatrist · Los Gatos, CANPI 1265927115
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (36.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Biotissue Holdings Inc. accounts for 60.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $8,614 and has fallen 72.2% since, to $2,398 in 2025. Among podiatrist clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $130.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$15K
- Evolution Surgical, Inc$2K
- Orthofix Medical, Inc.$1K
- Paragon 28, Inc.$1K
- Arthrex$1K
- Rock Medical Orthopedics, Inc.$1K
- plus $3K from 11 others
What the payments were for
- Consulting fees$6,15024%
- Speaking & faculty fees$3,00012%
- Travel & lodging$4,38317%
- Food & beverage$9,19237%
- Education$2,40010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 69 | $15,212 |
| Evolution Surgical, Inc | 8 | $1,913 |
| Orthofix Medical, Inc. | 13 | $1,409 |
| Paragon 28, Inc. | 5 | $1,210 |
| Arthrex | 10 | $1,202 |
| Rock Medical Orthopedics, Inc. | 1 | $1,200 |
| Smith+Nephew | 44 | $873 |
| Organogenesis Inc. | 18 | $563 |
| Stryker | 5 | $476 |
| Boston Scientific | 4 | $294 |
| Treace Medical Concepts, Inc. | 1 | $190 |
| Nevro Corp. | 2 | $166 |
| Mimedx Group, Inc. | 6 | $138 |
| Hydrofera LLC | 1 | $123 |
| Integra Lifesciences Corporation | 3 | $74 |
| Amgen | 2 | $52 |
| Vertex | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEOX$4,587
- CLARIX$1,587
- TrueLok$1,075
- Product Portfolio$865
- MONKEY RINGS$291
- PROstep$257
- Stravix$231
- Lapiplasty System$190
- ORTHOLOC 2 LAPIFUSE$158
- Senza$142
- PURAPLY WOUND MATRIX$140
- HYDROFERA BLUE$123
- WATCHMAN FLX$119
- GRAFIX PL$112
- Grafix XC$112
- STRAVIX PL$112
How this compares
$25,125 in reported general payments places this provider in the 95th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 12 | $13,257 |
| Mupirocin | 86 | $584 |
| Cephalexin | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $873 | $13,25712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 721 podiatrist providers in California.
Other podiatrist in Los Gatos
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.1M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- David ArmstrongLos Angeles$695K
- Philip WrotslavskyPoway$269K
- Travis WestermeyerEncinitas$158K
- Adrienne EstesPomona$129K
- Ronald LiebermanEncinitas$109K
- Matthew DoyleMountain View$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.